KPF
TENX icon

K2 Principal Fund’s Tenax Therapeutics TENX Stock Holding History

K2 Principal Fund’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Buy
+10,000
New +$128K 0.01% 357

Other funds holding TENX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

K2 Principal Fund's TENX Position: Q2 2026 in Review

K2 Principal Fund opened a new position in Tenax Therapeutics (TENX) in Q2 2026: 10,000 shares worth $146K. The stake represents 0.01% of the portfolio and ranks #357 among its holdings.

23 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • K2 Principal Fund held 10,000 shares of Tenax Therapeutics worth $146K as of Q2 2026.
  • Tenax Therapeutics was a new K2 Principal Fund position in Q2 2026.
  • Tenax Therapeutics made up 0.01% of K2 Principal Fund's portfolio in Q2 2026, its #357 holding.
  • 23 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.